{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "10/27/2025",
      "update_type": "New",
      "initial_posting_date": "10/27/2025",
      "package_ndc": "0310-6615-02",
      "generic_name": "Pramlintide Acetate Injection",
      "contact_info": "800-236-9933",
      "related_info": "Discontinuation of the manufacture of the drug.",
      "openfda": {
        "application_number": [
          "NDA021332"
        ],
        "brand_name": [
          "SYMLINPEN"
        ],
        "generic_name": [
          "PRAMLINTIDE ACETATE"
        ],
        "manufacturer_name": [
          "AstraZeneca Pharmaceuticals LP"
        ],
        "product_ndc": [
          "0310-6615",
          "0310-6627"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "PRAMLINTIDE ACETATE"
        ],
        "rxcui": [
          "861042",
          "861043",
          "861044",
          "861045"
        ],
        "spl_id": [
          "a84753f1-6ac5-4a47-a382-29972938ccaa"
        ],
        "spl_set_id": [
          "4aea30ff-eb0d-45c1-b114-3127966328ff"
        ],
        "package_ndc": [
          "0310-6615-02",
          "0310-6627-02"
        ],
        "unii": [
          "726I6TE06G"
        ]
      },
      "update_date": "10/27/2025",
      "therapeutic_category": [
        "Endocrinology/Metabolism"
      ],
      "dosage_form": "Injection",
      "presentation": "SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)",
      "company_name": "AstraZeneca AB",
      "status": "To Be Discontinued"
    }
  ]
}